153 related articles for article (PubMed ID: 25863548)
21. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of a provider-focused intervention to improve HPV vaccination rates in boys and girls.
Perkins RB; Zisblatt L; Legler A; Trucks E; Hanchate A; Gorin SS
Vaccine; 2015 Feb; 33(9):1223-9. PubMed ID: 25448095
[TBL] [Abstract][Full Text] [Related]
23. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
Paul P; Fabio A
Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
[TBL] [Abstract][Full Text] [Related]
24. County-Level Factors Associated With HPV Vaccine Coverage Among 11-Year-Olds to 12-Year-Olds Living in Florida in 2019.
Osegueda ER; Chi X; Hall JM; Vadaparampil ST; Christy SM; Staras SAS
J Adolesc Health; 2023 Jan; 72(1):130-137. PubMed ID: 36244897
[TBL] [Abstract][Full Text] [Related]
25. Understanding how different recruitment strategies impact parent engagement with an iPad-based intervention to provide personalized information about adolescent vaccines.
Dempsey AF; Maertens J; Beaty BL; O'Leary ST
J Adolesc Health; 2015 May; 56(5 Suppl):S7-13. PubMed ID: 25863557
[TBL] [Abstract][Full Text] [Related]
26. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
27. Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents.
Skinner SR; Cooper Robbins SC
J Adolesc Health; 2010 Sep; 47(3):215-8. PubMed ID: 20708557
[No Abstract] [Full Text] [Related]
28. Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(40):1100-3. PubMed ID: 18846032
[TBL] [Abstract][Full Text] [Related]
29. Immunization update: pertussis, meningoccocus, and human papillomavirus.
Middleman AB
Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279
[TBL] [Abstract][Full Text] [Related]
30. Adolescent immunization delivery in school-based health centers: a national survey.
Daley MF; Curtis CR; Pyrzanowski J; Barrow J; Benton K; Abrams L; Federico S; Juszczak L; Melinkovich P; Crane LA; Kempe A
J Adolesc Health; 2009 Nov; 45(5):445-52. PubMed ID: 19837350
[TBL] [Abstract][Full Text] [Related]
31. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
32. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
33. The HPV vaccine: are dosing recommendations being followed?
Tan W; Viera AJ; Rowe-West B; Grimshaw A; Quinn B; Walter EB
Vaccine; 2011 Mar; 29(14):2548-54. PubMed ID: 21300098
[TBL] [Abstract][Full Text] [Related]
34. Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years.
Wilson SE; Harris T; Sethi P; Fediurek J; Macdonald L; Deeks SL
Vaccine; 2013 Jan; 31(5):757-62. PubMed ID: 23246265
[TBL] [Abstract][Full Text] [Related]
35. Asking mom: formative research for an HPV vaccine campaign targeting mothers of adolescent girls.
Shafer A; Cates JR; Diehl SJ; Hartmann M
J Health Commun; 2011 Oct; 16(9):988-1005. PubMed ID: 21728780
[TBL] [Abstract][Full Text] [Related]
36. Early policy responses to the human papillomavirus vaccine in the United States, 2006-2010.
Laugesen MJ; Mistry R; Carameli KA; Ribisl KM; Needleman J; Bastani R
J Adolesc Health; 2014 Nov; 55(5):659-64. PubMed ID: 24928803
[TBL] [Abstract][Full Text] [Related]
37. Geospatial patterns in human papillomavirus vaccination uptake: evidence from uninsured and publicly insured children in North Carolina.
Trogdon JG; Ahn T
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):595-602. PubMed ID: 25576528
[TBL] [Abstract][Full Text] [Related]
38. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry.
Enger KS; Stokley S
J Adolesc Health; 2007 May; 40(5):398-404. PubMed ID: 17448396
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
Guerry SL; De Rosa CJ; Markowitz LE; Walker S; Liddon N; Kerndt PR; Gottlieb SL
Vaccine; 2011 Mar; 29(12):2235-41. PubMed ID: 21288799
[TBL] [Abstract][Full Text] [Related]
40. Successful Use of Interventions in Combination to Improve Human Papillomavirus Vaccination Coverage Rates Among Adolescents-Chicago, 2013 to 2015.
Choi N; Curtis CR; Loharikar A; Fricchione M; Jones E; Balzer E; Liu Y; Levin M; Chavez-Torres M; Morita J; Caskey R
Acad Pediatr; 2018 Mar; 18(2S):S93-S100. PubMed ID: 29502644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
